Source:http://linkedlifedata.com/resource/pubmed/id/16275081
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-11-25
|
pubmed:abstractText |
A series of acryloylamino-salicylanilides were synthesized as inhibitors of EGFR PTK. A strategy of pseudo six-membered ring formed through intramolecular hydrogen bonding in salicylanilides is employed to mimic the planar pyrimidine ring of quinazoline EGFR inhibitors. Acrylamido moiety is incorporated to target the Cys-773 of EGFR specifically. Some of the obtained compounds exhibited good activity as EGFR inhibitors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
469-72
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16275081-Crystallography, X-Ray,
pubmed-meshheading:16275081-Drug Design,
pubmed-meshheading:16275081-Models, Molecular,
pubmed-meshheading:16275081-Molecular Structure,
pubmed-meshheading:16275081-Protein-Tyrosine Kinases,
pubmed-meshheading:16275081-Receptor, Epidermal Growth Factor,
pubmed-meshheading:16275081-Salicylanilides,
pubmed-meshheading:16275081-Structure-Activity Relationship
|
pubmed:year |
2006
|
pubmed:articleTitle |
Acryloylamino-salicylanilides as EGFR PTK inhibitors.
|
pubmed:affiliation |
Department of Synthetic Medicinal Chemistry, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.
|
pubmed:publicationType |
Journal Article
|